A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

Who May Qualify: - At least 18 years of age. - Radical surgery for Cutaneous Malignant Melanoma (CMM) stage IIb-c and III. - Sufficient renal function for i.v. contrast scannings. Who Should NOT Join This Trial: - The patient is assessed as unfit to receive treatment in the case of recurrence. - Life-expectancy less than 2 years due to concurrent disease (e.g., cardiac disease, terminal multiple sclerosis, liver cirrhosis). - Inability to provide willing to sign a consent form or refusal to do so. - Inability to comply with the control or intense follow-up program. - Participation in other clinical trials interfering with the control-program. - Existing or previous malignancies within the past 5 years (except for in situ breast and cervical cancer, melanoma in situ and non-melanoma skin cancer). - Pregnancy or currently planned pregnancy. Always talk to your doctor about whether this trial is right for you.